Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Blackrock Inc

CME Group

Cummins

Honeywell

Intercontinental Exchange

Iron Mountain

Illinois Tool Works

Coca-Cola

Leggett & Platt

Medtronic

Realty Income Corp

Omega Healthcare Investors

S&P Global

AT&T

Thermo Fisher Scientific

Tractor Supply

Twilio

Unilever

Visa

Yum China Hlds

Analyzing my real-life portfolio's dividend growth for 2022. Dividend growth pulled back some compared to 2021; however, it was still a strong year of dividend growth.

Dividend Growth Checkup - 2022

Juul rebranded three times, sold assets, and attracted nontraditional investors. Now, it's reportedly in partnership talks with big tobacco companies.

E-cig startup Juul is talking to Philip Morris, Altria, and Japan Tobacco about its future, WSJ reports. Here's a rundown of the startup's rise and fall.

Juul is looking for a new backer as FDA order banning its vaporette remains in limbo pending trial. Talks have included Philip Morris, Japan Tobacco Group, and Altria.

Juul in deal talks with three tobacco giants

E-cigarette maker Juul Labs Inc is in early talks with three tobacco giants for a potential sale, strategic investment, licensing or distribution deal, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.

Juul in deal talks with three tobacco giants - WSJ

Philip Morris

Japan Tobacco Inc

The e-cigarette maker is exploring a potential sale, investment or distribution deal with Philip Morris, Japan Tobacco or Altria.

Juul in Deal Talks With Three Tobacco Giants

Although the company should continue to see a decline in cigarette volume, given the declining market and higher inflation, pricing growth will likely help offset the revenue loss from volume.

What To Expect From Altria's Q4?

These cheap, high-yield stocks could strengthen your portfolio.

2 Top Dividend Stocks for Protection Against a Recession in 2023

Cisco Systems

McDonald's

Mondelez

Procter & Gamble

Public Storage

Walmart

While it may be tough to sell this to somebody who just finished going to the grocery store, inflation is finally falling.

Inflation Finally Slows and 7 ‘Strong Buy' Dividend Stocks Look Like Big 2023 Winners

Last week, Altria stock plummeted as investors panicked over the formidable challenges looming ahead for the company. Given Philip Morris' leadership, Altria faces the daunting task of proving to investors its ability to dominate the smokeless tobacco market.

Altria: Mispriced For Doom And Gloom

The cigarette maker's stock has pulled back and offers a generous yield, but there are some key risks to consider here.

Altria Is Down 20% From Its High. Time to Buy?

You'll be able to sleep well at night knowing this stock is in your portfolio.

Want Low Volatility In 2023? Buy This Tobacco Stock With a High Dividend Yield

LyondellBasell Industries

Verizon

Sometimes the market has a flash sale and adding more shares is just too tempting to pass up. I put a much larger amount of cash to work compared to previous months ending 2022.

Recent Stock Purchase January 2023

Juul Labs Inc won preliminary approval of a settlement aimed at ending thousands of lawsuits alleging the company was a major cause of a youth-vaping epidemic in the United States, according to a court filing on Friday.

U.S. judge grants preliminary approval to Juul settlement

CTO Realty Growth

Magellan Midstream Partners

Certificates of deposit are now yielding close to 5% at some of the most well-known online banks. That means investors focused solely on income yield will likely have to take on more and more risk to justify their equity investments.

3 Stocks With 8%+ Yields And 10 Consecutive Years Of Dividend Growth

Broadstone Net Lease

Hess Midstream Partners

Innovative Industrial Properties

Moelis

New year, new investment opportunities. This month's dividend growth screener article presents ideas worth exploring further.

January's 5 Dividend Growth Stocks With 6.16%+ Yields

Recession fears have suddenly hit names that typically offer safety during recession. Neither pricing power concerns nor stock overvaluation applies to Altria Group, Inc.

Altria Sells Off For All The Wrong Reasons

AbbVie

Amgen

Boeing

General Dynamics

Johnson & Johnson

Kimberly-Clark

Kenvue

L3Harris

Lockheed Martin

Merck

Northrop Grumman

Raytheon Technologies

Investing in blue-chip companies that pay dividends and relentlessly focusing on reinvesting the proceeds is a proven strategy for reliable long-term returns. But what about the occasional black swan? Potentially devastating litigation? Overlooked liabilities on the balance sheet? Financial engineering?

Blue-Chip Stocks And Red Flags - Things To Consider In Your Due Diligence

RICHMOND, Va.--( BUSINESS WIRE )--Altria Group, Inc. (Altria) (NYSE: MO) will host a live audio webcast on Wednesday, February 1, 2023, at 9:00 a.m. Eastern Time to discuss its 2022 fourth-quarter and full-year business results. Altria will issue a press release containing its business results at approximately 7:00 a.m. Eastern Time the same day. The webcast can be accessed at altria.com.

Altria to Host Webcast of 2022 Fourth-Quarter and Full-Year Results

During times of market volatility, it's good to take a step back and search for stability. The tobacco industry is generally seen as a declining industry. However, this isn't actually the case.

Should You Buy 8.2%-Yielding Altria Ahead Of A Recession?

Altria Group (MO) has been troubled by cost woes and soft volumes in the Smokeable Products segment.

Altria (MO) Troubled by High Costs, Soft Smokeable Volumes

Bunge Global SA

Lowe's

Microsoft

Pfizer

Constellation Brands

The adage that it “takes two to tango” is spot-on when discussing the U.S. economy this year.

Goldman Sachs Has 6 ‘Hard Landing' Dividend Stocks to Buy Now in Case 2023 Blows Up

News for Altria Stock (MO)